Cover Image

Pharmacokinetic Characterization to Enable Medicine Use in Pregnancy, the Potential Role of Physiologically‐Based Pharmacokinetic Modeling: A Regulatory Perspective

Saved in:

Bibliographic Details
Main Authors:	Susan Cole (Author), Paola Coppola (Author), Essam Kerwash (Author), Janet Nooney (Author), Siu Ping Lam (Author)
Format:	Book
Published:	Wiley, 2020-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Physiologically Based Pharmacokinetics Model in Pregnancy: A Regulatory Perspective on Model Evaluation
by: Paola Coppola, et al.
Published: (2021)

Total and Free Blood and Plasma Concentration Changes in Pregnancy for Medicines Highly Bound to Plasma Proteins: Application of Physiologically Based Pharmacokinetic Modelling to Understand the Impact on Efficacy
by: Paola Coppola, et al.
Published: (2023)

Investigation of a fully mechanistic physiologically based pharmacokinetics model of absorption to support predictions of milk concentrations in breastfeeding women and the exposure of infants: A case study for albendazole
by: Susan Cole, et al.
Published: (2024)

Physiologically Based Pharmacokinetic Modelling of UGT Substrate Drugs Lamotrigine and Raltegravir during Pregnancy
by: Monika Berezowska, et al.
Published: (2024)

Casgevy: Innovative Medicinal Products Require Innovative Approaches to Regulatory Assessment
by: Essam Kerwash, et al.
Published: (2024)

Physiologic and Pharmacokinetic Changes in Pregnancy
by: Maged eCostantine
Published: (2014)

Pharmacokinetic Characterization of Supinoxin and Its Physiologically Based Pharmacokinetic Modeling in Rats
by: Yoo-Kyung Song, et al.
Published: (2021)

Utility of Physiologically Based Pharmacokinetic Modeling to Investigate the Impact of Physiological Changes of Pregnancy and Cancer on Oncology Drug Pharmacokinetics
by: Xinxin Yang, et al.
Published: (2023)

The Importance of the Human Mass Balance Study in Regulatory Submissions
by: Paola Coppola, et al.
Published: (2019)

Characterizing Pharmacokinetics in Children With Obesity-Physiological, Drug, Patient, and Methodological Considerations
by: Jacqueline G. Gerhart, et al.
Published: (2022)

Unravelling bisphenol A pharmacokinetics using physiologically based pharmacokinetic modeling
by: Xiaoxia eYang, et al.
Published: (2015)

Prediction of Pharmacokinetics of IDP-73152 in Humans Using Physiologically-Based Pharmacokinetics
by: Myongjae Lee, et al.
Published: (2022)

Physiologically‐based pharmacokinetic model to investigate the effect of pregnancy on risperidone and paliperidone pharmacokinetics: Application to a pregnant woman and her neonate
by: Walaa Y. B. Mahdy, et al.
Published: (2023)

Predicting Resolvin D1 Pharmacokinetics in Humans with Physiologically‐Based Pharmacokinetic Modeling
by: Venkata K. Yellepeddi, et al.
Published: (2021)

Development of best practices in physiologically based pharmacokinetic modeling to support clinical pharmacology regulatory decision‐making-A workshop summary
by: Daphney Jean, et al.
Published: (2021)

Regulatory utility of physiologically based pharmacokinetic modeling for assessing food impact in bioequivalence studies: A workshop summary report
by: Abdullah Al Shoyaib, et al.
Published: (2023)

Development of a physiologically‐based pharmacokinetic model to simulate the pharmacokinetics of intramuscular antiretroviral drugs
by: Sara Bettonte, et al.
Published: (2024)

Population pharmacokinetic analysis of rivaroxaban in children and comparison to prospective physiologically‐based pharmacokinetic predictions
by: Stefan Willmann, et al.
Published: (2021)

Application of Physiologically Based Pharmacokinetic Modeling to Predict Maternal Pharmacokinetics and Fetal Exposure to Oxcarbazepine
by: Lixia He, et al.
Published: (2022)

Application of a physiologically based pharmacokinetic model to predict isoniazid disposition during pregnancy
by: Ogochukwu U. Amaeze, et al.
Published: (2023)

Regulatory utility of physiologically‐based pharmacokinetic modeling to support alternative bioequivalence approaches and risk assessment: A workshop summary report
by: Fang Wu, et al.
Published: (2023)

Physiologically-Based Pharmacokinetic Modelling to Predict the Pharmacokinetics and Pharmacodynamics of Linezolid in Adults and Children with Tuberculous Meningitis
by: Carlijn H. C. Litjens, et al.
Published: (2023)

Physiologically‐Based Pharmacokinetic Modeling vs. Allometric Scaling for the Prediction of Infliximab Pharmacokinetics in Pediatric Patients
by: Paul R. V. Malik, et al.
Published: (2019)

A Physiologically‐Based Pharmacokinetic Model for the Prediction of Monoclonal Antibody Pharmacokinetics From In Vitro Data
by: Hannah M. Jones, et al.
Published: (2019)

The Effect of Liver and Kidney Disease on the Pharmacokinetics of Clozapine and Sildenafil: A Physiologically Based Pharmacokinetic Modeling
by: Ghoneim AM, et al.
Published: (2020)

Physiologically-Based Pharmacokinetic (PBPK) Modeling Providing Insights into Fentanyl Pharmacokinetics in Adults and Pediatric Patients
by: Lukas Kovar, et al.
Published: (2020)

Analysis of Time-Dependent Pharmacokinetics Using In Vitro-In Vivo Extrapolation and Physiologically Based Pharmacokinetic Modeling
by: Min-Chang Kim, et al.
Published: (2022)

An Application of a Physiologically Based Pharmacokinetic Approach to Predict Ceftazidime Pharmacokinetics in a Pregnant Population
by: Khaled Abduljalil, et al.
Published: (2024)

First-in-human study to investigate the safety and pharmacokinetics of salvianolic acid A and pharmacokinetic simulation using a physiologically based pharmacokinetic model
by: Jinliang Chen, et al.
Published: (2022)

Physiologically Based Pharmacokinetic Modeling in Pregnancy, during Lactation and in Neonates: Achievements, Challenges and Future Directions
by: Karel Allegaert, et al.
Published: (2024)

Physiologically based pharmacokinetic modeling to predict the pharmacokinetics of codeine in different CYP2D6 phenotypes
by: Yujie Yang, et al.
Published: (2024)

Utility of physiologically based pharmacokinetic modeling to predict inter-antibody variability in monoclonal antibody pharmacokinetics in mice
by: Shufang Liu, et al.
Published: (2023)

A physiologically based pharmacokinetic model of cefepime to predict its pharmacokinetics in healthy, pediatric and disease populations
by: Muhammad Talha Zahid, et al.
Published: (2023)

A Comprehensive Physiologically Based Pharmacokinetic Model for Predicting Vildagliptin Pharmacokinetics: Insights into Dosing in Renal Impairment
by: Mahnoor Pasha, et al.
Published: (2024)

MEGen: A Physiologically Based Pharmacokinetic Model Generator
by: George D Loizou, et al.
Published: (2011)

Modelling Tools to Characterize Acetaminophen Pharmacokinetics in the Pregnant Population
by: Sofie A. M. Brookhuis, et al.
Published: (2021)

Stereospecific pharmacokinetic characterization of liquiritigenin in the rat
by: Samaa Alrushaid, et al.
Published: (2017)

A Minimal Physiologically Based Pharmacokinetic Model to Characterize CNS Distribution of Metronidazole in Neuro Care ICU Patients
by: Alexia Chauzy, et al.
Published: (2022)

Pharmacokinetics of Anthraquinones from Medicinal Plants
by: Dongpeng Wang, et al.
Published: (2021)

Physiologically based pharmacokinetic modeling of drug-drug interactions between ritonavir‐boosted atazanavir and rifampicin in pregnancy
by: Shakir Atoyebi, et al.
Published: (2024)